Christopher Posner's Net Worth
$511 Thousand
Who is Christopher Posner?
Christopher Posner does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cara Therapeutics, Inc., and KEMPHARM, INC.
SEC CIK
Christopher Posner's CIK is 0001748265
Past Insider Trading and Trends
2021 was Christopher Posner's most active year for acquiring shares with 5 total transactions. Christopher Posner's most active month to acquire stocks was the month of May. 2023 was Christopher Posner's most active year for disposing of shares, totalling 5 transactions. Christopher Posner's most active month to dispose stocks was the month of October. 2021 saw Christopher Posner paying a total of $0.00 for 731,941 shares, this is the most they've acquired in one year. In 2022 Christopher Posner cashed out on 16,476 shares for a total of $186,467.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cara Therapeutics, Inc. (CARA) Snapshot price: $0.532
PRESIDENT AND CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.18% | -3.94K |
$0.75 | -$2,952.00 | 176.59K |
May 2
| |||
Form 4
| -3.13% | -5.83K |
$0.89 | -$5,192.26 | 180.52K |
Feb 29
| |||
Form 4
| -16.03% | -35.58K |
$0.53 | -$18,854.75 | 186.35K |
Feb 8
| |||
Form 4
| +34.98% | 57.52K |
$0.55 | -$2,739.55 | 221.93K |
Feb 1
| |||
Form 4
| -2.26% | -3.80K |
$1.22 | -$4,631.12 | 164.41K |
Nov 2
| |||
Form 4
| -2.50% | -4.31K |
$3.07 | -$13,222.49 | 168.21K |
Aug 3
| |||
Form 4
| -2.19% | -3.87K |
$4.40 | -$17,023.60 | 172.51K |
May 5
| |||
Form 4
| -3.28% | -5.99K |
$9.71 | -$58,133.77 | 176.38K |
Scheduled
|
Mar 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| -2.25% | -4.19K |
$11.80 | -$49,453.80 | 182.37K |
Scheduled
|
Feb 2
| ||
Form 4
| -7.20% | -14.47K |
$11.13 | -$161,051.10 | 186.56K |
Scheduled
|
Nov 16
| ||
Form 4
| -0.99% | -2.01K |
$12.67 | -$25,416.02 | 201.03K |
Scheduled
|
Apr 4
| ||
Form 4
| +23.78% | 39K |
—
|
—
| 203.04K |
Feb 25
| |||
Form 4
| +919.12% | 147.94K |
—
|
—
| 164.04K |
Oct 29
| |||
Form 4
| +43.71% | 4.9K |
$13.04 | -$30,044.16 | 16.1K |
Scheduled
|
Jun 3 - Jun 7
| ||
Form 4
| -15.15% | -2.00K |
$15.82 | -$31,638.00 | 11.2K |
Nov 19
| |||
Form 4
| +120.00% | 7.2K |
—
|
—
| 13.2K |
Jun 4
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KEMPHARM, INC (ZVRA) Snapshot price: $5.765
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||